TRCT
RPID icon

Tower Research Capital (TRC)’s Rapid Micro Biosystems RPID Stock Holding History

Tower Research Capital (TRC)’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.29K Buy
+1,900
New +$4K ﹤0.01% 4553
2026
Q1 		– Sell
-317
Closed -$919 – 5498
2025
Q4 		$919 Buy
+317
New +$1.1K ﹤0.01% 4795
2025
Q2 		– Sell
-350
Closed -$924 – 5528
2025
Q1 		$924 Sell
350
-8,770
-96% -$20K ﹤0.01% 4800
2024
Q4 		$8.21K Buy
9,120
+4,513
+98% +$4.54K ﹤0.01% 4011
2024
Q3 		$4.1K Sell
4,607
-3,689
-44% -$2.87K ﹤0.01% 4672
2024
Q2 		$5.47K Buy
8,296
+2,749
+50% +$2.35K ﹤0.01% 4675
2024
Q1 		$5.38K Sell
5,547
-4,260
-43% -$4.14K ﹤0.01% 4550
2023
Q4 		$7.26K Buy
9,807
+6,655
+211% +$6.81K ﹤0.01% 4639
2023
Q3 		$3.4K Sell
3,152
-710
-18% -$706 ﹤0.01% 5009
2023
Q2 		$3.86K Sell
3,862
-708
-15% -$716 ﹤0.01% 5017
2023
Q1 		$6K Sell
4,570
-5,831
-56% -$7.57K ﹤0.01% 4866
2022
Q4 		$12K Sell
10,401
-6,962
-40% -$16.9K ﹤0.01% 3737
2022
Q3 		$56K Buy
17,363
+7,645
+79% +$29.7K ﹤0.01% 3068
2022
Q2 		$42K Buy
9,718
+8,199
+540% +$38.2K ﹤0.01% 3063
2022
Q1 		$10K Buy
1,519
+520
+52% +$3.83K ﹤0.01% 4338
2021
Q4 		$11K Buy
999
+210
+27% +$3.28K ﹤0.01% 4446
2021
Q3 		$15K Buy
+789
New +$16.3K ﹤0.01% 3993

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $8.55M AUM 12.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EFA
Evernest Financial Advisors Carmel, Indiana $478M AUM 24% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Tower Research Capital (TRC)'s RPID Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in Rapid Micro Biosystems (RPID) in Q2 2026: 1,900 shares worth $3.29K. The stake represents ﹤0.01% of the portfolio and ranks #4553 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in RPID as recently as Q4 2025.

Tower Research Capital (TRC) first reported a position in RPID in Q3 2021 and has held it in 17 quarters since. The position peaked at $56K in Q3 2022. 34 funds tracked by Wall St. Rank hold RPID as of Q2 2026.

  • Tower Research Capital (TRC) held 1,900 shares of Rapid Micro Biosystems worth $3.29K as of Q2 2026.
  • Rapid Micro Biosystems was a new Tower Research Capital (TRC) position in Q2 2026.
  • Rapid Micro Biosystems made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4553 holding.
  • Tower Research Capital (TRC) first reported a position in Rapid Micro Biosystems in Q3 2021 and has held it in 17 quarters since.
  • Tower Research Capital (TRC)'s Rapid Micro Biosystems position peaked at $56K in Q3 2022.
  • 34 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.